+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transplantation Market Research Report by Product, by Application, by End Use - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5124085
  • Report
  • July 2020
  • Region: United States
  • 93 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 21st Century Medicine
  • BioLIfe Solutions
  • Novartis
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals
  • MORE
The United States Transplantation Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Transplantation Market.

Market Segmentation & Coverage:

This research report categorizes the Transplantation market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Transplantation Market studied across Immunosuppressive Drugs and Tissue Products.

Based on Application, the Transplantation Market studied across Organ Transplantation and Tissue Transplantation.

Based on End Use, the Transplantation Market studied across Hospitals and Transplant Centers.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States Transplantation Market including 21st Century Medicine, BioLIfe Solutions, Novartis, Teva Pharmaceuticals, and Veloxis Pharmaceuticals.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transplantation Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Transplantation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Transplantation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Transplantation Market?
4. What is the competitive strategic window for opportunities in the United States Transplantation Market?
5. What are the technology trends and regulatory frameworks in the United States Transplantation Market?
6. What are the modes and strategic moves considered suitable for entering the United States Transplantation Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 21st Century Medicine
  • BioLIfe Solutions
  • Novartis
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Product Outlook
3.3. Application Outlook
3.4. End Use Outlook
3.5. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Transplantation Market, By Product
6.1. Introduction
6.2. Immunosuppressive Drugs
6.3. Tissue Products

7. United States Transplantation Market, By Application
7.1. Introduction
7.2. Organ Transplantation
7.3. Tissue Transplantation

8. United States Transplantation Market, By End Use
8.1. Introduction
8.2. Hospitals
8.3. Transplant Centers

9. Competitive Strategic Window
9.1. Introduction
9.2. Competitive Strategic Window, by Product
9.3. Competitive Strategic Window, by Application
9.4. Competitive Strategic Window, by End Use

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles
11.1. 21st Century Medicine
11.2. BioLIfe Solutions
11.3. Novartis
11.4. Teva Pharmaceuticals
11.5. Veloxis Pharmaceuticals

12. Appendix
12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details

LIST OF FIGURES
FIGURE 1. UNITED STATES TRANSPLANTATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES TRANSPLANTATION MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES TRANSPLANTATION MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES TRANSPLANTATION MARKET, BY TYPE
FIGURE 8. UNITED STATES TRANSPLANTATION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES TRANSPLANTATION MARKET: MARKET DYNAMICS
FIGURE 10. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
FIGURE 11. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2019 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2025 (USD MILLION)
FIGURE 16. UNITED STATES TRANSPLANTATION MARKET: FPNV POSITIONING MATRIX
FIGURE 17. UNITED STATES TRANSPLANTATION MARKET: MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. UNITED STATES TRANSPLANTATION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES TRANSPLANTATION MARKET SIZE, BY TISSUE PRODUCTS, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES TRANSPLANTATION MARKET SIZE, BY ORGAN TRANSPLANTATION, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES TRANSPLANTATION MARKET SIZE, BY TISSUE TRANSPLANTATION, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES TRANSPLANTATION MARKET SIZE, BY HOSPITALS, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES TRANSPLANTATION MARKET: SCORES
TABLE 9. UNITED STATES TRANSPLANTATION MARKET: BUSINESS STRATEGY
TABLE 10. UNITED STATES TRANSPLANTATION MARKET: PRODUCT SATISFACTION
TABLE 11. UNITED STATES TRANSPLANTATION MARKET: RANKING
TABLE 12. UNITED STATES TRANSPLANTATION MARKET: MERGER & ACQUISITION
TABLE 13. UNITED STATES TRANSPLANTATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 14. UNITED STATES TRANSPLANTATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 15. UNITED STATES TRANSPLANTATION MARKET: INVESTMENT & FUNDING
TABLE 16. UNITED STATES TRANSPLANTATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 17. UNITED STATES TRANSPLANTATION MARKET: EDITION DETAILS
TABLE 18. UNITED STATES TRANSPLANTATION MARKET: LICENSE DETAILS
TABLE 19. UNITED STATES TRANSPLANTATION MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
3 of 3
  • 21st Century Medicine
  • BioLIfe Solutions
  • Novartis
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals
Note: Product cover images may vary from those shown
Adroll
adroll